MARATTO

peer review

Author response: A modified BCG with depletion of enzymes associated with peptidoglycan amidation induces enhanced protection against tuberculosis in mice

Abstract

The new vaccine candidate for tuberculosis displays superior protection against disease when compared the currently available vaccine, and can potentially provide new options for global childhood vaccination programs.

Research topics

  • Immune responses and vaccinations
  • Tuberculosis Research and Epidemiology

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.7554/elife.89157.sa2

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.